参考文献/References:
[1] ZHANG Bing ,JIA Yejing ,WANG Jing, et al. Colorimetric and photothermal dual-mode immunoassayfor tumour marker detection based on a Ag2CO3 @Agnanocomposite[J]. Process Biochemistry, 2019, 87: 66-72.
[2] ZHANG Hai, TAVAKOLIAN P, SIVAGURUNATHANK, et al. Truncated-correlation photothermal coherencetomography derivative imaging modality for smallanimal in vivo early tumor detection[J].Optics Letters,2019, 44(3):675-682.
[3] OVERGAAUW A J C, SPEIJERS‐VAN DER PLASL M, HENDRIKS M P, et al. Outcome and feasibilityof palliative chemotherapy in very elderly patients withmetastatic breast cancer[J].The Breast Journal, 2020,26(3): 433-439.
[4] ALBERS A E, KAUFMANN A M. EGFR im Speichel:neuer Tumormarker für Plattenepithelkarzinom imMund [J]. Laryngo- Rhino- Otologie, 2018, 97(5): 302-303.
[5] RENARD A S, NEDELCU C, PAISANT A, et al. Ismultidetector CT-scan able to detect T3a renal tumorbefore surgery?[J]. Scandinavian Journal of Urology,2019, 53(5): 350-355.
[6] SHIOGA T, KONDO R, OGASAWARA S, et al. Usefulness of tumor tissue biopsy for predicting the biological behavior of hepatocellular carcinoma[J]. Anticancer Research, 2020, 40(7): 4105-4113.
[7] TAKAKURA M, MATSUMOTO T, NAKAMURA M,et al. Detection of circulating tumor cells in cervicalcancer using a conditionally replicative adenovirustargeting telomerase-positive cells[J]. Cancer Science,2018, 109(1): 231-240.
[8] YU Yue, CHEN Zhaoli, DONG Jingsi, et al. FolateReceptor-Positive circulating tumor cells as a noveldiagnostic biomarker in non-small cell lung cancer[J].Translational Oncology, 2013, 6(6): 697-702.
[9] ZHANG Xiaofen,JU Shaoqing,WANG Xudong, et al.Advances in liquid biopsy using circulating tumor cellsand circulating cell-free tumor DNA for detection andmonitoring of breast cancer[J]. Clinical and Experimental Medicine, 2019, 19(3): 271-279.
[10] FENIZIA F. Oncogenomics// Circulating Tumor Cellsand ctDNA in NSCLC[M].Ytaly Naples: AcademicPress, 2019:465-475.
[11] UDAYAN G, MARSELLA A, VALENTINI P. An ultrasensitive colorimetric test for the detection of somaticrare mutations in DNA[J]. Nanoscale, 2020, 12(5):2973-2979.
[12] LENAERTS L, TUVERI S, JATSENKO T, et al. Detection of incipient tumours by screening of circulatingplasma DNA: hype or hope?[J]. Acta Clinica Belgica,2020, 75(1): 9-18.
[13] OLIVEIRA M, RUIZ-PACE F, MATITO J, et al.Determinants of concordance in clinically relevantgenes(CRG)from synchronously acquired tumor biopsies(tBx)and ctDNA in metastatic breast cancer(MBC)[J]. Journal of Clinical Oncology, 2019, 37(15 suppl):1075.
[14] MACGREGOR-DAS A，YU Jun，TAMURA K,etal. Detection of circulating tumor DNA in Patientswith pancreatic cancer using digital next-generationsequencing(article)[J]. The Journal of Molecular Diagnostics, 2020, 22(6): 748-756.
[15] GAO Fangyuan, JIAO Fenglong, XIA Chaoshuang, etal. A novel strategy for facile serum exosome isolationbased on specific interactions between phospholipidbilayers and TiO2[J]. Chemical Science, 2019, 10(6):1579-1588.
[16] LIANG Jinying, ZHANG Xinxin, HE Shufang, et al.Sphk2 RNAi nanoparticles suppress tumor growthvia downregulating cancer cell derived exosomalmicroRNA [J].Journal of Controlled Release, 2018,286: 348-357.
[17] LOGOZZI M, MIZZONI D, CAPASSO C, et al. Plasmatic exosomes from prostate cancer patients showincreased carbonic anhydrase IX expression and activity and low pH[J]. Journal of Enzyme Inhibition andMedicinal Chemistry, 2020, 35(1): 280-288.
[18] BIJNSDORP I，EROZENCI L A，KOETSIER J，et al. The prostate cancer urinary exosome protein biomarker landscape[J].European Urology Open Science,2020, 19(S2):e517-e518.
[19] JUBAIR S,ALKHATEEB A,TABL A A, et al. A novelapproach to identify subtype-specific network biomarkers of breast cancer survivability[J]. Network ModelingAnalysis in Health Informatics and Bioinformatics,2020, 9(1): 256-i319.
[20] ALI A H. Current knowledge of buttermilk:Composition,applications in the food industry,nutritional andbeneficial health characteristics[J].International Journal of Dairy Technology, 2019, 72(2): 169-182.
[21] PARK J, HWANG M, CHOI B, et al. Exosome classification by pattern analysis of Surface-Enhanced raman spectroscopy data for lung cancer diagnosis[J]. Analytical Chemistry, 2017, 89(12): 6695-6701.
[22] VANNI I, ALAMA A, GROSSI F, et al. Exosomes: anew horizon in lung cancer[J]. Drug Discovery Today,2017, 22(6): 927-936.
[23] GAO Chao,FAN Fan, LIU Xin, et al. Exosomal miRNAanalysis of aqueous humour of diabetes and cataractpatients[J]. Current Eye Research, https://doi.org/10.1080/02713683.2020.1797107.
[24] WANG Jianjun, LIU Yuanyuan, SUN Wangwei, et al.Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer [J]. Cancer Biomarkers, 2018,21(4): 805-812.
[25] ZONG Shenfei，WANG Le，CHEN Chen, et al.Facile detection of tumor-derived exosomes using magnetic nanobeads and SERS nanoprobes[J]. AnalyticalMethods, 2016, 8(25): 5001-5008.
[26] ZHAO Zheng, YANG Yang, ZENG Yong, et al. A microfluidic ExoSearch chip for multiplexed exosomedetection towards blood-based ovarian cancer diagnosis[J]. Lab on a Chip, 2016, 16(3): 489-496.
[27] JEONG S, PARK J, PATHANIA D, et al. Integratedmagneto-electrochemical sensor for exosome analysis[J]. ACS Nano, 2016, 10(2): 1802-1809.
[28] DOLD?N X, FAG?NDEZ P, CAYOTA A, et al. Electrochemical sandwich immunosensor for determinationof exosomes based on surface Marker-Mediated signalamplification[J]. Analytical Chemistry, 2016, 88(21):10466-10473.
[29] WAN Shuo, ZHANG Liqin, WANG Sai, et al. Molecular Recognition-Based DNA nanoassemblies on the surfaces of nanosized exosomes[J]. Journal of the American Chemical Society, 2017, 139(15): 5289-5292.
[30] XIA Yaokun ，LIU Mengmeng ，WANG Liangliang,et al. A visible and colorimetric aptasensor based onDNA-capped single-walled Carbon nanotubes for detection of exosomes[J]. Biosensors & Bioelectronics,2017, 92: 8-15.
[31] ZHOU Qing, RAHIMIAN A, SON K, et al. Development of an aptasensor for electrochemical detection ofexosomes[J].Methods, 2016, 97:88-93.
[32] JIANG Ying, SHI Muling, LIU Yuan, et al. Aptamer/AuNP biosensor for colorimetric profiling of exosomal proteins[J]. Angewandte Chemie (International ed. inEnglish), 2017, 56(39): 11916-11920.
[33] CHEN Xiaosong, LAN Jianming, LIU Yingxin, et al. Apaper-supported aptasensor based on upconversion luminescence resonance energy transfer for the accessibledetermination of exosomes [J]. Biosensors & Bioelectronics,2018, 102:582-588.
[34] WANG Sai, ZHANG Liqin, WAN Shuo, et al. Aptasensor with expanded nucleotide using DNA nanotetrahedra for electrochemical detection of cancerousexosomes [J]. ACS Nano, 2017, 11(4):3943-3949.
[35] DAABOUL G G, GAGNI P, BENUSSI L, et al. Digitaldetection of exosomes by interferometric imaging[J].Scientific Reports, 2016, 6(1):203-219.
[36] OLIVEIRA-RODR?GUEZ M, L?PEZ-COBO S, REYBURN H T, et al. Development of a rapid lateral flow immunoassay test for detection of exosomes previouslyenriched from cell culture medium and body fluids[J]. Journal of Extracellular Vesicles, 2016, 5(1): 31803.
相似文献/References:
[1]祖瑞铃,叶波.不同肿瘤与并发胰腺炎患者血清AMY和LPS的分布水平及实验诊断价值研究[J].现代检验医学杂志,2019,34(01):76.[doi:10.3969/j.issn.1671-7414.2019.01.019]
ZU Rui-ling,YE Bo.Distributions and Diagnostic Values of Serum Amylase and Lipase
in Patients with Various Types of Tumors and Those with Pancreatitis[J].Journal of Modern Laboratory Medicine,2019,34(03):76.[doi:10.3969/j.issn.1671-7414.2019.01.019]
[2]王李秦,魏绪仓.Galectin-4与肿瘤相关性的研究进展[J].现代检验医学杂志,2019,34(01):161.[doi:10.3969/j.issn.1671-7414.2019.01.042]
WANG Li-qin,WEI Xu-cang.Research of Galectin-4 in Tumor[J].Journal of Modern Laboratory Medicine,2019,34(03):161.[doi:10.3969/j.issn.1671-7414.2019.01.042]
[3]左二冬,代 卫,陆 晔,等.放疗相关性贫血患者血清Hepcidin，EPO 表达特征[J].现代检验医学杂志,2020,35(02):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
ZUO Er-dong,DAI Wei,LU Ye,et al.Expression Features of Serum Hepcidin and EPO in Tumor Patients withRadiotherapy-Related Anemia[J].Journal of Modern Laboratory Medicine,2020,35(03):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
[4]王秋云,严 敏,程 珍,等.肿瘤及血液病患者血清 sTRAIL表达及与 IL-6和 Hepcidin水平的相关性研究[J].现代检验医学杂志,2021,36(01):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]
WANG Qiu-yun,YAN Min,CHENG Zhen,et al.Study of the Expression of the Serum sTRAIL, and Its Correlation with Levels of Serum IL-6 and Hepcidin in the Patients with the Tumor and Hematological Diseases[J].Journal of Modern Laboratory Medicine,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]
[5]胥 劲,何 訸,黄亨建.液体活检技术在上尿路上皮癌精准诊治中的最新应用研究进展[J].现代检验医学杂志,2021,36(04):171.[doi:10.3969/j.issn.1671-7414.2021.04.037]
XU Jin,HE He,HUANG Heng-jian.Advances in the Application of Liquid Biopsy Technique in the PreciseDiagnosis and Treatment of Upper Urothelial Carcinoma[J].Journal of Modern Laboratory Medicine,2021,36(03):171.[doi:10.3969/j.issn.1671-7414.2021.04.037]
[6]刘 霄a,黄晓燕b,王建华a.长链非编码RNASNHG9在不同肿瘤中的最新研究进展[J].现代检验医学杂志,2021,36(04):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
LIU Xiaoa,HUANG Xiao-yanb,WANG Jian-huaa.Reasearch Progress of Long Non-coding RNA SNHG9 in Different Tumors[J].Journal of Modern Laboratory Medicine,2021,36(03):176.[doi:10.3969/j.issn.1671-7414.2021.04.038]
[7]刘振亚,赵慧敏,王临艳.血清淀粉样蛋白A 与肿瘤诊断、分期和预后相关性研究进展[J].现代检验医学杂志,2023,38(03):207.[doi:10.3969/j.issn.1671-7414.2023.03.039]
LIU Zhen-ya,ZHAO Hui-min,WANG Lin-yan.Advances on the Correlation between Serum Amyloid A and Cancer Diagnosis, Stage and Prognosis[J].Journal of Modern Laboratory Medicine,2023,38(03):207.[doi:10.3969/j.issn.1671-7414.2023.03.039]
[8]刁 迅,范绮雨,耿良栋,等.基于生物信息学分析双硫死亡相关基因PDLIM1 mRNA在多种肿瘤中的表达及临床应用价值[J].现代检验医学杂志,2024,39(01):36.[doi:10.3969/j.issn.1671-7414.2024.01.007]
DIAO Xun,FAN Qiyu,GENG Liangdong,et al.Analysis of Expression in Disulfidptosis-Related Gene PDLIM1 mRNA in Various Tumors and Its Clinical Application Value Based on Bioinformatics[J].Journal of Modern Laboratory Medicine,2024,39(03):36.[doi:10.3969/j.issn.1671-7414.2024.01.007]
[9]张志远,郑 直,田晓怡.融合基因检测方法的最新研究进展[J].现代检验医学杂志,2024,39(05):205.[doi:10.3969/j.issn.1671-7414.2024.05.038]
ZHANG Zhiyuan,ZHENG Zhi,TIAN Xiaoyi.Advancements in Latest Fusion Gene Detection Methods: A Comprehensive Review[J].Journal of Modern Laboratory Medicine,2024,39(03):205.[doi:10.3969/j.issn.1671-7414.2024.05.038]